AUBERTON-HERVE ANDRE-JACQUES 4
4 · Bionik Laboratories Corp. · Filed Jun 15, 2018
Insider Transaction Report
Form 4
AUBERTON-HERVE ANDRE-JACQUES
Director
Transactions
- Conversion
Common Stock
2018-06-13$0.06/sh+1,040,152$65,010→ 14,758,703 total(indirect: Shares held through Star SCI) - Conversion
Common Stock
2018-06-13$0.06/sh+1,039,115$64,945→ 14,758,703 total(indirect: Shares held through 4A Consulting and Engineering)
Footnotes (2)
- [F1]As previously disclosed by the reporting person on a Form 4, filed with the Securities and Exchange Commission on April 3, 2018, as of March 31, 2018, the Issuer became obligated to issue 1,010,152 shares of common stock (the "Star Shares") to Star SCI, an affiliate of the reporting person, as a result of the conversion of certain outstanding convertible promissory notes in accordance with their terms. The reporting person is filing this Form 4 to disclose that the Issuer issued the Star Shares as of June 13, 2018.
- [F2]As previously disclosed by the reporting person on a Form 4, filed with the Securities and Exchange Commission on April 3, 2018, as of March 31, 2018, the Issuer became obligated to issue 1,039,115 shares of common stock (the "4A Shares") to 4A Consulting and Engineering, an affiliate of the reporting person, as a result of the conversion of certain outstanding convertible promissory notes in accordance with their terms. The reporting person is filing this Form 4 to disclose that the Issuer issued the 4A Shares as of June 13, 2018.